These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3318428)

  • 21. A longterm endoscopic evaluation of patients with arthritis treated with nabumetone vs naproxen.
    Roth SH; Bennett R; Caldron P; Mitchell C; Swenson C; Koepp R
    J Rheumatol; 1994 Jun; 21(6):1118-23. PubMed ID: 7932425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of the efficacy and safety of nabumetone and diclofenac sodium in the treatment of patients with rheumatoid arthritis].
    Zhonghua Yi Xue Za Zhi; 2001 May; 81(9):557-60. PubMed ID: 11809123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.
    Hedner T; Samulesson O; Währborg P; Wadenvik H; Ung KA; Ekbom A
    Drugs; 2004; 64(20):2315-43; discussion 2344-5. PubMed ID: 15456329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee.
    Weaver A; Rubin B; Caldwell J; McMahon FG; Lee D; Makarowski W; Offenberg H; Sack M; Sikes D; Trapp R
    Clin Ther; 1995; 17(4):735-45. PubMed ID: 8565037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of the effectiveness and safety of two non-steroidal anti-inflammatory agents, nabumetone and naproxen in rheumatoid arthritis.
    Fostiropoulos G; Croydon EA
    J Int Med Res; 1982; 10(4):204-8. PubMed ID: 6749576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The long-term U.S. study--a report on outcome and tolerance.
    Fleischmann R
    Eur J Rheumatol Inflamm; 1991; 11(3):50-3. PubMed ID: 1365481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nabumetone. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases.
    Friedel HA; Todd PA
    Drugs; 1988 May; 35(5):504-24. PubMed ID: 3293969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nabumetone: a clinical appraisal.
    Helfgott SM
    Semin Arthritis Rheum; 1994 Apr; 23(5):341-6. PubMed ID: 8036523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of the experience with nabumetone in clinical trials outside of the United States.
    Jenner PN; Johnson ES
    Am J Med; 1987 Oct; 83(4B):110-4. PubMed ID: 3318421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter study of nabumetone and diclofenac SR in patients with osteoarthritis.
    Bellamy N; Bensen WG; Beaulieu A; Siminovitch KA; Kraag GR; Lussier A; Ahmad S; Khanna VN; Davis P; Bell MJ
    J Rheumatol; 1995 May; 22(5):915-20. PubMed ID: 8587082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-blind, placebo-controlled comparison of the safety and efficacy of orally administered etodolac and nabumetone in patients with active osteoarthritis of the knee.
    Schnitzer TJ; Ballard IM; Constantine G; McDonald P
    Clin Ther; 1995; 17(4):602-12. PubMed ID: 8565024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative gastrointestinal blood loss associated with placebo, aspirin, and nabumetone as assessed by radiochromium (51Cr).
    Lussier A; Davis A; Lussier Y; Lebel E
    J Clin Pharmacol; 1989 Mar; 29(3):225-9. PubMed ID: 2786009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and improved safety--a new anti-arthritic agent.
    Irani M
    Eur J Rheumatol Inflamm; 1991; 11(3):43-9. PubMed ID: 1365480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. German drug monitoring studies with nabumetone.
    Stroehmann I; Fedder M; Zeidler H
    Drugs; 1990; 40 Suppl 5():38-42. PubMed ID: 2081491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nabumetone (Relifex)--another NSAID.
    Drug Ther Bull; 1988 May; 26(11):41-3. PubMed ID: 3289871
    [No Abstract]   [Full Text] [Related]  

  • 36. Radiochromium (chromium-51) evaluation of gastrointestinal blood loss associated with placebo, aspirin, and nabumetone.
    Lussier A; LeBel E
    Am J Med; 1987 Oct; 83(4B):15-8. PubMed ID: 3500642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy and tolerance of nabumetone in articular and non-articular rheumatic disorders: personal experience during 12 weeks of treatment.
    Coaccioli S; Allegra A; Di Cato L; Puxeddu A
    Panminerva Med; 1998 Jun; 40(2):110-5. PubMed ID: 9689831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of the long-term safety experience of nabumetone.
    Willkens RF
    Drugs; 1990; 40 Suppl 5():34-7. PubMed ID: 2081490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized double-blind study of nabumetone and piroxicam in the treatment of osteoarthritis in Dutch general practice: efficacy and tolerability.
    De Bock GH; Hermans J; Mulder JD
    Pharm World Sci; 1993 Jun; 15(3):132-8. PubMed ID: 8348110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of tolerability and efficacy of a nabumetone preparation in the treatment of patients with rheumatoid arthritis].
    Alianti M; Lotta C; Vaiani G
    Clin Ter; 1990 Jun; 133(5):299-308. PubMed ID: 2143713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.